2009China Healthcare FrontiersRequires access

Clinical observation on efficacy of Edaravone in treatment of patients with acute cerebral infarction

Wang Li

Open publisher page 0 citations

Abstract

Objective To investigate the edaravone treatment of acute cerebral infarction. Methods 100 cases of acute cerebral infarction were randomly divided into treatment group and control group, 50 cases in each group, control group with conventional treatment, the treatment group in the conventional treatment plus edaravone injection for efficacy evaluation. Results The total effective rate (84%) was significantly better than the control group (64%), neurological deficit scores improve significantly (P 0.05, treatment group and control group compared to the onset time, the treatment group was significantly earlier than the control group, there was a significant difference. Conclusion edaravone injection can effectively improve the acute cerebral infarction and neurological deficits in activities of daily living, and better able to control the progress of cerebral infarction.

About this research paper

What this paper is about

Objective To investigate the edaravone treatment of acute cerebral infarction. Methods 100 cases of acute cerebral infarction were randomly divided into treatment group and control group, 50 cases in each group, control group with conventional treatment, the treatment group in the conventional treatment plus edaravone injection for efficacy evaluation. Results The total effective rate (84%) was significantly better than the control group (64%), neurological deficit scores improve significantly (P 0.05, treatment group and control group compared to the onset time, the treatment group was significantly earlier than the control group, there was a significant difference. Conclusion edaravone injection can effectively improve the acute cerebral infarction and neurological deficits in activities of daily living, and better able to control the progress of cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the edaravone treatment of acute cerebral infarction. Methods 100 cases of acute cerebral infarction were randomly divided into treatment group and control group, 50 cases in each group, control group with conventional treatment, the treatment group in the conventional treatment plus edaravone injection for efficacy evaluation. Results The total effective rate (84%) was significantly better than the control group (64%), neurological deficit scores improve significantly (P 0.05, treatment group and control group compared to the onset time, the treatment group was significantly earlier than the control group, there was a significant difference. Conclusion edaravone injection can effectively improve the acute cerebral infarction and neurological deficits in activities of daily living, and better able to control the progress of cerebral infarction.

Key concepts: Edaravone, Medicine, Cerebral infarction, Clinical efficacy, Neurological deficit, Anesthesia, Treatment and control groups, Conventional treatment

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on efficacy of Edaravone in treatment of patients with acute cerebral infarction — Research Paper | ScholarLens